✦ LIBER ✦

Early use of clinical BRCA1/2 testing: Associations with race and breast cancer risk

✍ Scribed by Katrina Armstrong; Barbara Weber; Jill Stopfer; Kathleen Calzone; Mary Putt; James Coyne; J. Sanford Schwartz

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 76 KB
Volume: 117A
Category: Article
ISSN: 1552-4825
DOI: 10.1002/ajmg.a.10928

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical management of BRCA1- and BRCA2-

Clinical management of BRCA1- and BRCA2-associated breast cancer

✍ Stephen E. Karp 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

The recent discovery of the breast cancer-associated genes BRCA1 and BRCA2 has changed the clinical care provided to women at high risk of breast cancer. We will review what is currently known about the clinical management of patients who bear (or are suspected of bearing) mutations in either of the

Mutation analysis of the BRCA1 and BRCA2

Mutation analysis of the BRCA1 and BRCA2 genes results in the identification of novel and recurrent mutations in 6/16 Flemish families with breast and/or ovarian cancer but not in 12 sporadic patients with early-onset disease

✍ Kathleen Claes; Eva Machackova; Michel De Vos; Geert Mortier; Anne De Paepe; Lud 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 1 views

Germline mutations within the adenomatous polyposis coli (APC) gene, a tumor suppressor gene, are responsible for most cases of familial adenomatous polyposis (FAP), an autosomal dominantly inherited predisposition to colorectal cancer. To date, more than 300 germ-line causative mutations within thi

Phosphorylation of ERK1/2 mitogen-activa

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

✍ Julia M.W. Gee; John F.R. Robertson; Ian O. Ellis; Robert I. Nicholson 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 207 KB 👁 1 views